fda safety communication semaglutide naion 2025 New lawsuits claim that certain GLP-1 medications may be linked to sudden vision loss. Patients across the United States say they developed a rare optic nerve condition called NAION, which can reduce FDA Issues 30 Warning Letters
Pay in 4 interest-free payments of $6.82 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 14 - Oct 19








.jpg?auto=format%2Ccompress&fmt=webp&width=720)









:format(webp))







